822 related articles for article (PubMed ID: 25752738)
21. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
Pizzorno A; Abed Y; Rhéaume C; Boivin G
Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
[TBL] [Abstract][Full Text] [Related]
22. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
[TBL] [Abstract][Full Text] [Related]
23. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
[TBL] [Abstract][Full Text] [Related]
24. Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Harada T; Ishimatsu Y; Hara A; Morita T; Nakashima S; Kakugawa T; Sakamoto N; Kosai K; Izumikawa K; Yanagihara K; Mukae H; Kohno S
J Pharmacol Exp Ther; 2016 Sep; 358(3):457-63. PubMed ID: 27489022
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
Bantia S; Upshaw R; Babu YS
Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
Lee J; Park JH; Jwa H; Kim YH
Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
[TBL] [Abstract][Full Text] [Related]
27. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
[TBL] [Abstract][Full Text] [Related]
30. Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
Sato M; Ito M; Suzuki S; Sakuma H; Takeyama A; Oda S; Watanabe M; Hashimoto K; Miyazaki K; Kawasaki Y; Hosoya M
Antimicrob Agents Chemother; 2015 Mar; 59(3):1643-9. PubMed ID: 25547357
[TBL] [Abstract][Full Text] [Related]
31. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.
Yamaya M; Nadine L; Kubo H; Saito K; Saito R; Nishimura H
J Med Virol; 2015 Jan; 87(1):25-34. PubMed ID: 24838828
[TBL] [Abstract][Full Text] [Related]
32. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
33. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
34. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
35. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
[TBL] [Abstract][Full Text] [Related]
36. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
[TBL] [Abstract][Full Text] [Related]
37. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
[TBL] [Abstract][Full Text] [Related]
38. Progranulin Decreases Susceptibility to
Wang X; Yuan J; Wang H; Gan N; Zhang Q; Liu B; Wang J; Shu Z; Rao L; Gou X; Zhang H; Yin Y; Zhang X
J Immunol; 2019 Oct; 203(8):2171-2182. PubMed ID: 31519865
[No Abstract] [Full Text] [Related]
39. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
40. Peramivir for the treatment of influenza.
Shetty AK; Peek LA
Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
